middle.news
How TrivarX’s Veteran Mental Health Trial and Brain Tumor Tech Could Disrupt Diagnostics
8:46am on Friday 31st of October, 2025 AEDT
•
Healthcare
Read Story
How TrivarX’s Veteran Mental Health Trial and Brain Tumor Tech Could Disrupt Diagnostics
8:46am on Friday 31st of October, 2025 AEDT
Key Points
Interim trial results show high sensitivity in detecting major depressive episodes
Patient recruitment completed with 60 veterans enrolled in US trial
Binding agreement signed to acquire Stabl-Im™ brain tumor imaging technology
Post-quarter $4.2 million placement secured to fund acquisition and development
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Trivarx (ASX:TRI)
OPEN ARTICLE